NCT06406400: A trial that was reported late by AstraZeneca
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT06406400 |
|---|---|
| Title | A Two-Part Study to Examine the Drug-Drug Interaction With Itraconazole and Safety of AZD4041 in Healthy Participants and the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 as an Adjunctive Treatment to Buprenorphine in Participants With Moderate to Severe Opioid Use Disorder |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 13, 2024 |
| Completion date | July 30, 2024 |
| Required reporting date | July 30, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 27, 2025 |
| Days late | None |